Histone Deacetylase Inhibitors Are Protective in Acute but Not in Chronic Models of Ototoxicity

Previous studies have reported that modification of histones alters aminoglycoside-induced hair cell death and hearing loss. In this study, we investigated three FDA-approved histone deacetylase (HDAC) inhibitors (vorinostat/SAHA, belinostat, and panobinostat) as protectants against aminoglycoside-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chao-Hui, Liu, Zhiqi, Dong, Deanna, Schacht, Jochen, Arya, Dev, Sha, Su-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660723/
https://www.ncbi.nlm.nih.gov/pubmed/29114207
http://dx.doi.org/10.3389/fncel.2017.00315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660723/
https://www.ncbi.nlm.nih.gov/pubmed/29114207
http://dx.doi.org/10.3389/fncel.2017.00315

Ejemplares similares